0000929638-25-001453.txt : 20250402 0000929638-25-001453.hdr.sgml : 20250402 20250402161323 ACCESSION NUMBER: 0000929638-25-001453 CONFORMED SUBMISSION TYPE: SCHEDULE 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20250402 DATE AS OF CHANGE: 20250402 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: InMed Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001728328 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: SCHEDULE 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-91842 FILM NUMBER: 25804618 BUSINESS ADDRESS: STREET 1: 1445-885 WEST GEORGIA ST. CITY: VANCOUVER STATE: A1 ZIP: V6C 3E8 BUSINESS PHONE: (604) 669-7207 MAIL ADDRESS: STREET 1: 1445-885 WEST GEORGIA ST. CITY: VANCOUVER STATE: A1 ZIP: V6C 3E8 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: AdvisorShares Trust CENTRAL INDEX KEY: 0001408970 ORGANIZATION NAME: EIN: 260636087 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: SCHEDULE 13G/A BUSINESS ADDRESS: STREET 1: 4800 MONTGOMERY LANE STREET 2: SUITE 150 CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: (877) 843-3831 MAIL ADDRESS: STREET 1: 4800 MONTGOMERY LANE STREET 2: SUITE 150 CITY: BETHESDA STATE: MD ZIP: 20814 SCHEDULE 13G/A 1 primary_doc.xml SCHEDULE 13G/A 0000929638-24-003817 0001408970 XXXXXXXX LIVE 1 Common Shares, no par value 03/31/2025 0001728328 InMed Pharmaceuticals Inc. 457637601 Suite 1445 - 885 W. Georgia Street Vancouver A1 00000 Rule 13d-1(b) AdvisorShares Trust DE 0 0 0 0 0 N 0 IV InMed Pharmaceuticals Inc. Suite 1445 - 885 W. Georgia Street, Vancouver, British Columbia, Canada, 00000 AdvisorShares Trust 4800 Montgomery Lane, Suite 150 Bethesda, Maryland 20814 Delaware N IV 0 0 0 0 0 0 N Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. AdvisorShares Trust /s/ Stefanie Lititle 04/02/2025